[Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker]

Ter Arkh. 2008;80(9):5-12.

[Article in Russian]

Authors

Iu N Belenkov, V Iu Mareev, A A Skvortsov

PMID: 19555028

No abstract available

Publication types

Editorial

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Disease Progression
Drug Therapy, Combination
Heart Failure / drug therapy*
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use*
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Mineralocorticoid Receptor Antagonists